http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_db16989d9ab0941f944bf673c449ea90
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | M. Evens Evens |
| name | Andrew M Evens Andrew M. Evens |
| given-name | Andrew M Andrew M. Andrew |
| organization-name | Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA 3Department of Hematology and Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ Division for Hematology/Oncology, Tufts Medical Center, Boston, MA, USA;; Tufts University School of Medicine, Boston, MA, USA; Department of Biomedical and Health Sciences Rutgers Cancer Institute of New Jersey New Brunswick New Jersey USA From the Division of Hematology/Oncology, Department of Medicine, and the Division of Hematopathology, Department of Pathology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL. Division of Hematology/OncologyTufts University School of Medicine Boston MA USA 1Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Division of Hematology/Oncology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA; Division of Hematology and Oncology, Tufts University School of Medicine and Cancer Center, Boston, MA, USA; Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA; Division of Hematology/Oncology Tufts University School of Medicine Boston MA USA 1Medicine and Division of Hematology/Oncology, Departments of; 3Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois Division of Hematology/Oncology Tufts Medical Center Boston MA USA Division of Hematology/Oncology The University of Massachusetts Medical School and the UMass Memorial Cancer Center Worcester MA USA Division of Blood Disorders, Rutgers Cancer Institute, New Brunswick, NJ, USA; Feinberg School of Medicine, Northwestern University, Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois 60611, USA. [email protected] 2Division of Hematology/Oncology, Department of Internal Medicine, Northwestern University Feinberg School of Medicine, Chicago, IL Oliver W. Press, Fred Hutchinson Cancer Research Center, and the University of Washington; Hongli Li and Michael LeBlanc, Fred Hutchinson Cancer Research Center, Seattle, WA; Heiko Schöder, David J. Straus, Craig H. Moskowitz, and Ariela Noy, Memorial Sloan Kettering Cancer Center; John P. Leonard, Weill Cornell Medical College and New York Presbyterian Hospital, New York City; Paul M. Barr and Jonathan W. Friedberg, University of Rochester Medical Center, Rochester, NY; Lisa M. Rimsza, University of... From the Division of Hematology/Oncology, Department of Medicine, Department of Pathology, and Department of Pediatrics, Feinberg School of Medicine, and The Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, IL; and Department of Medical Oncology and Department of Pathology, British Columbia Cancer Agency, Vancouver, British Columbia, Canada. Division of Hematology/Oncology, Department of Medicine, Northwestern University Medical School and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA. [email protected] Department of Hematology/Oncology, Tufts Medical Center, Boston, Massachusetts. 19Tufts University Medical Center, Boston, Massachusetts. Northwestern University, Chicago IL; From the Division of Hematology/Oncology, Department of Medicine, Department of Pathology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL; and Pharmacyclics, Inc, Sunnyvale, CA. 3Division of Hematology and Oncology, Tufts Medical Center, Boston, Massachusetts. Department of Medicine, Division of Blood Disorders, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA Tufts University Medical Center, Boston, MA; and Rutgers Cancer Institute of New Jersey New Brunswick New Jersey USA 1Division of Hematology Oncology and Molecular Oncology Research Institute, Tufts Medical Center, Boston, Massachusetts. Department of Medicine, Division of Hematology/Oncology, Lutheran General Hospital, and Lutheran General Hospital Cancer Care Center, Park Ridge, Illinois, USA Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA Rutgers Cancer Institute of New Jersey New Brunswick New Jersey Division of Hematology & Oncology, Tufts Medical Center, Boston, MA Division of Hematology/Oncology, The University of Massachusetts Medical School and the UMass Memorial Cancer Center, Worcester, MA; and Authors' Affiliation: Division of Hematology/Oncology, Department of Medicine, Lymphoma Program, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, Illinois 8Division of Hematology-Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ Rutgers Cancer Institute of New Jersey, New Brunswick From the Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center; Departments of Preventive Medicine and of Pathology, Division of Solid Organ Transplantation, Northwestern University Feinberg School of Medicine; Division of Hematology/Oncology, University of Chicago; and Hematology Department, Rush University Medical Center, Chicago; and Division of Hematology/Oncology, Loyola University Medical Center, Maywood, IL. Division of Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL;; Robert H. Lurie Comprehensive Cancer Center, Chicago, IL; Authors' Affiliations: 1NYU Cancer Institute, NYU Langone Medical Center; 2Department of Medicine, Lymphoma Service, and Departments of 3Statistics and 4Radiology, Memorial Sloan-Kettering Cancer Center, New York, New York; 5University of Nebraska, Department of Medicine, Omaha, Nebraska; 6Robert H. Lurie Comprehensive Cancer Center, Northwester University, Department of Medicine, Chicago, Illinois; 7Drug Development Branch, CTEP, National Cancer Institute, Bethesda, Maryland; and 8University Hospitals of Cleveland, Comprehensive Cancer Center, Case Western Reserve University, Department of Medicine, Cleveland, Ohio Division of Hematology/Oncology The University of Massachusetts Medical School Worcester MA USA Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Andrew M. Evens, Tufts University School of Medicine, Boston; Aimee Kroll-Desrosiers, University of Massachusetts Medical School, Worcester, MA; Ranjana Advani and Stavroula Otis, Stanford University Medical Center, Stanford, CA; Oliver W. Press and Linda M. Parker, Fred Hutchinson Cancer Research Center, Seattle, WA; Izidore S. Lossos, Liat Nadav Dagan, and Jose Sandoval, University of Miami School of Medicine, Miami, FL; Julie M. Vose, University of Nebraska Medical Center, Omaha, NE; Francisco J.... Division of Hematology/Oncology Tufts University Medical Center, Boston, MA; Tufts Medical School, Boston, MA Division of Hematology/Oncology Department Medicine UMass Memorial Medical Center University of Massachusetts Medical School Worcester MA USA 1 Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ Hematology/Oncology The University of Massachusetts Medical School Worcester MA USA Division of Hematology/Oncology Tufts University Boston Massachusetts USA 1Division of Hematology/Oncology, Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center, Chicago, Illinois and Andrew M. Evens, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; Ranjana H. Advani, Stanford University, Stanford, CA; Irene B. Helenowski, Borko D. Jovanovic, Jane N. Winter, and Leo I. Gordon, Northwestern University Feinberg School of Medicine; Jane N. Winter and Leo I. Gordon, Robert H. Lurie Comprehensive Cancer Center; Sonali M. Smith, University of Chicago, Chicago, IL; Michelle Fanale, University of Texas MD Anderson Cancer Center, Houston, TX; Gregory R. Bociek, University of Nebraska... Tufts Medical Center Tufts University School of Medicine Boston Massachusetts Division of Hematology-Oncology, Tufts Medical Center, Boston, MA; and Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, USA Division of Hematology-Oncology, Director, Tufts Cancer Center, Tufts Medical Center, 800 Washington Street, Box #245, Boston, MA 02111, USA The University of Massachusetts Medical School Worcester MA USA 1Molecular Oncology Research Institute and Division of Hematology Oncology, Tufts Medical Center, Department of Medicine, Tufts University School of Medicine, Boston, Massachusetts. Rutgers Robert Wood Johnson Medical School New Brunswick New Jersey USA; Rutgers Cancer Institute of New Jersey New Brunswick New Jersey USA; Lymphoma Program Division of Blood Disorders New Brunswick New Jersey USA; Oncology Service Line RWJBarnabas Health West Orange New Jersey USA Division of Hematology/Oncology, Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA. Division of Hematology/Oncology, University of Massachusetts Medical School, Worcester, MA; Authors' Affiliations: 1Lymphoma Program, Division of Hematology/Oncology, The Robert H. Lurie Comprehensive Cancer Center; Departments of 2Radiology/Nuclear Medicine, 3Preventive Medicine, and 4Pathology, Northwestern University Feinberg School of Medicine, Chicago, Illinois; and 5Pharmacyclics, Inc., Sunnyvale, California Rutgers Robert Wood Johnson Medical School, New Brunswick, New Jersey. Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey. Division of Blood Disorders, RWJBarnabas Health, New Brunswick, New Jersey. Oncology Service Line, RWJBarnabas Health, New Brunswick, New Jersey. 1Division of Hematology/Oncology, Tufts Medical Center, Boston, Massachusetts. Division of Hematology/Oncology, Tufts Medical Center and Tufts University School of Medicine, Boston, MA; Michael Lishner, Meir Medical Center, Kfar Saba, and Tel Aviv University; Irit Avivi, Ichilov Medical Center, Tel Aviv, Israel; Jane F. Apperley, Hammersmith Hospital; Susan Robinson, Guy's and St Thomas' National Health Service Foundation Trust, London; Frank Van den Heuvel, University of Oxford, Oxford, United Kingdom; Andrew M. Evens, Tufts Medical Center, Boston, MA; Monica Fumagalli, University of Milan; Fedro Alessandro Peccatori, European Institute of Oncology, Milan, Italy; Irena Nulman,... Division of Hematology/Oncology Tufts University School of Medicine Boston Massachusetts The University of Massachusetts Medical School and University of Massachusetts Memorial Cancer Center, Worcester, MA Division of Blood Disorders, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ; and Tufts Cancer Center, Division of Hematology/Oncology, Tufts Medical Center, Boston, MA, USA.; Tufts University School of Medicine, Boston, MA, USA. Tufts Medical Center, Boston, Massachusetts. Tufts Medical Center Boston Massachusetts Rutgers Cancer Institute of New Jersey New Brunswick NJ USA From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago, IL; Division of Hematology and Diagnostic Radiology, Mayo Clinic, Rochester, MN; Department of Imaging Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX; and Medical Research, Biogen Idec, San Diego, CA. Department of Medicine, Division of Hematology/Oncology Northwestern University Feinberg School of Medicine and the Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL 60611, USA. |
Incoming Links
Showing number of triples: 1 to 254 of 254.